In the United States, prescription drug rebates are a central piece in the overall economic value proposition for medications manufacturers. Drug rebates are complex and the subject of legislative influence, creating a uniquely challenging ecosystem where gaps in knowledge, data and technology can create systemic and potentially costly challenges for all stakeholders who provide patients with life-saving and life-changing treatments.
Request Free! |
Meeting the Challenges of Commercial Drug Rebate Programs with Technology
In the United States, prescription drug rebates are a central piece in the overall economic value proposition for medications manufacturers. Drug rebates are complex and the subject of legislative influence, creating a uniquely challenging ecosystem where gaps in knowledge, data and technology can create systemic and potentially costly challenges for all stakeholders who provide patients with life-saving and life-changing treatments.
Request Free! |